2British Thoracic Society Standards of Care Committee. British thoracic society guidelines for the management of community acquired pneumonia in childhood [ J ]. Thorax, 2002,57 ( Supply 1 ) : 1 - 24.
4Wise R, Andrews JM, Thomber D. The in-vitro activity of cefdinir (FK482), a new oral cephalo sporin[ J ]. J Antimicrob Chemother, 1991,2.8 (28) :239 - 248.
5Jones RN. In vitro antibacterial activity of oral cephalosporins[J] ; Clin Drug Invest, 1995,9(Suppl) :22 - 30.
6Nagate T, Akashi T, Numata K, et al. In vitro and in vivo antibacterial activity and pharmacokinetics of SC - 002 and its derivative[J]. SC-004: New oral cephalosporins[ J ]. Chemotherapy,2001,47(3) : 157 - 169.
二级参考文献3
1[1]Goto S, Ogawa M, Kaneko Y, et al. In vitro and in vivo antibacterial activities of cefdinir, a new oral cephalosporin[J].Chemotherapy, 1989;37 (S- 2): 30 - 35.
2[2]Yourassousky E, Van der linden M, Crokaet F. Comparative kill and growth rates determined with cefdinir and cefaclor and with Streptococcus pneumoniae and β- lactamase producing Haemophilus influenzae[J]. Antimicrob Agents Chemother, 1992;36:46 - 51.
3[3]Margaret D, Patrick B, Constance H. Comparison of cefdinir and cefaclor in the treatment of community - acquired pneumoniae[J]. Antimicrob Agents Chemother, 1997;41:1579- 1583.
7Pichichero ME, Doern GV, Kuti JL, et al. Probability of achieving requisite pharmacodynamic exposure for oral beta - lactam regimens against Haemophilus influenzae in children[J]. Paediatr Drugs, 2008,10 (6) : 391.
8Brook Itzhak, MD, MSc.A pooled comparison of cefdinir and penicillin in the treatment of group a beta-hemolytic streptococcal pharyngotonsillitis[J].Clin Ther, 2005, 27 (8) : 1 266.
10Block SL, Cifaldi M, Gu Y, et al. A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, singleblind study[J]. Clin Ther, 2005,27(6) : 786.
